Evidence map›Paper›PMID 25887954›Full record

ArticleCritical care (London, England)2015

β₁-adrenoceptor stimulation promotes LPS-induced cardiomyocyte apoptosis through activating PKA and enhancing CaMKII and IκBα phosphorylation.

Yiyang Wang, Yuan Wang, Duomeng Yang, Xiaohui Yu, Hongmei Li, Xiuxiu Lv, Daxiang Lu, Huadong Wang

Open access · goldAbstract read
In one paragraph

Article in Critical care (London, England), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 1 synthesis or guideline pooled it, 82 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Increased Risk of Heart Failure in Elderly Patients Treated with Beta-Blockers After AV Node Ablation.American journal of cardiovascular drugs : drugs, devices, and other interventions · 2023
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Yiyang WangDepartment of Pathophysiology, School of Medicine, Jinan University, Guangzhou, 510632, Guangdong, China. ywang98@gsu.edu.
Yuan WangDepartment of Pathophysiology, School of Medicine, Jinan University, Guangzhou, 510632, Guangdong, China. wangyuan602@126.com.
Duomeng YangDepartment of Pathophysiology, School of Medicine, Jinan University, Guangzhou, 510632, Guangdong, China. 1319069233@qq.com.
Xiaohui YuDepartment of Pathophysiology, School of Medicine, Jinan University, Guangzhou, 510632, Guangdong, China. yuxiaohui0319@foxmail.com.
Hongmei LiDepartment of Pathophysiology, School of Medicine, Jinan University, Guangzhou, 510632, Guangdong, China. lihongmei083@qq.com.
Xiuxiu LvDepartment of Pathophysiology, School of Medicine, Jinan University, Guangzhou, 510632, Guangdong, China. 2541519018@qq.com.
Daxiang LuDepartment of Pathophysiology, School of Medicine, Jinan University, Guangzhou, 510632, Guangdong, China. ldx@jnu.edu.cn.
Huadong WangDepartment of Pathophysiology, School of Medicine, Jinan University, Guangzhou, 510632, Guangdong, China. owanghd@jnu.edu.cn.
Jinan University · CNState Administration of Traditional Chinese Medicine of the People's Republic of China · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionCaspase activation and cardiomyocyte apoptosis have been implicated in lipopolysaccharide (LPS)-induced cardiac contractile dysfunction. We have recently demonstrated that β1-adrenoceptor (AR) activation by endogenous norepinephrine contributes to cardiomyocyte apoptosis in endotoxemic mice. Here, we further investigated the molecular mechanisms for the enhancing effect of β₁-AR activation on LPS-induced cardiomyocyte apoptosis.

methodsThe adult mouse ventricular myocytes were exposed to LPS, dobutamine, protein kinase A (PKA) inhibitor or/and nifedipine, an L-type Ca(2+) channel blocker. Male BALB/c mice were treated with LPS or/ and β₁-AR antagonist, atenolol. Cardiomyocyte apoptosis was determined by terminal deoxynucleotidyl transferase-mediated dUTP nick-end-labeling (TUNEL) assay and apoptosis-associated molecules were detected.

resultsLPS induced apoptosis in adult mouse ventricular myocytes, dobutamine (DOB), a β₁-AR agonist, promoted apoptosis, caspase-8, 9 and 3 activation and increased cytosolic Ca(2+) concentration in LPS-challenged cardiomyocytes. DOB also up-regulated TNF-α expression, decreased Bcl-2 levels, promoted Bax translocation to mitochondria, mitochondrial membrane potential loss and cytochrome c release as well as IκBα, p38 MAPK, JNK and Ca(2+)/calmodulin-dependent protein kinase II (CaMKII) phosphorylation in LPS-treated cardiomyocytes. PKA inhibitor abolished the effects of DOB on caspase-9 activation, Bcl-2 levels as well as JNK and p38 MAPK phosphorylation, but not on IκBα phosphorylation, TNF-α expression and caspase-8 activation in LPS-stimulated cardiomyocytes. Pretreatment with nifedipine not only significantly blocked the enhancing effects of DOB on LPS-induced elevation in cytosolic Ca(2+) concentration and CaMKII phosphorylation in cardiomyocytes, but also partly reversed the effects of DOB on caspase-9 and caspase-3/7 activities in LPS-treated cardiomyocytes. Furthermore, atenolol suppressed TNF-α expression, JNK, p38 MAPK and CaMKII phosphorylation, increased Bcl-2 expression, and inhibited cytochrome c release and cardiomyocyte apoptosis in the myocardium of endotoxemic mice.

conclusionsβ1-AR activation promotes LPS-induced apoptosis through activating PKA, increasing CaMKII phosphorylation as well as enhancing IκBα phosphorylation and TNF-α expression in cardiomyocytes.

Indexed as

Adrenergic beta-1 Receptor AgonistsAnimalsApoptosisCalcium-Calmodulin-Dependent Protein Kinase Type 2Calcium Channel BlockersCaspasesCyclic AMP-Dependent Protein KinasesDobutamineEndotoxemiaLipopolysaccharidesMaleMiceMice, Inbred BALB CMyocardial ContractionMyocardiumMyocytes, CardiacAdrenergic beta-1 Receptor AgonistsCalcium-Calmodulin-Dependent Protein Kinase Type 2Calcium Channel BlockersCaspasesCyclic AMP-Dependent Protein KinasesDobutamineLipopolysaccharidesNifedipineNorepinephrinep38 Mitogen-Activated Protein KinasesReceptors, Adrenergic, beta-1

Identifiers

PMID25887954
PMCPMC4383083
OpenAlexW2127331803

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.